Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers saw a response rate of 91% across groups.

Immunotherapy. 2012;4(9):939-945. The percentage of patients achieving complete clearance of their AKs in the 5-FU group was 19, 28.2 and 52.6% in the 1-, 2- and 4-week treatment groups, respectively.

(CBSNews)--The U.S. Food and Drug Administration is warning pet owners of the risks associated with a skin cancer cream after five dogs were died after accidentally ingesting it. The topical cancer ...

Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912) No significant financial ...

Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Extrovis AG, a global pharmaceutical company focused on research-driven ...

Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its ...

Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.